Arkolith/Insider Trading/PHAT/Form 4

Parikh Asit

DirectorPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed May 8, 2025
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 7, 2025Buy(P)5K$2.40$12K96K
May 6, 2025Buy(P)5K$2.60$13K91K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-067237) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML